Global POC Molecular Diagnostics Market 2024-2028

Global Poc Molecular Diagnostics Market 2024-2028

The poc molecular diagnostics market is forecasted to grow by USD 1140.3 mn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the poc molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increase in adoption of microarrays in genomics and proteomics, and increased focus on personalized medicine.

Technavio's poc molecular diagnostics market is segmented as below:

By Product

• PCR
• Microarray and hybridization

By Application

• Infectious diseases
• Oncology
• Hematology and endocrinology
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing focus on technological advances as one of the prime reasons driving the poc molecular diagnostics market growth during the next few years. Also, rising focus on next-generation products and paradigm shift toward mirnas will lead to sizable demand in the market.

The report on the poc molecular diagnostics market covers the following areas:

• Poc molecular diagnostics market sizing
• Poc molecular diagnostics market forecast
• Poc molecular diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading poc molecular diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., binx health inc., bioMerieux SA, Co Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., Pfizer Inc., QIAGEN NV, QuantuMDx Group Ltd., Quidelortho Corp., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp, and Thermo Fisher Scientific Inc.. Also, the poc molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.